Methylation and expression analysis of p16INK4a and RB genes in meningiomas

Chinese Journal of Medical Genetics

Volumn 21, Issue 3, 2004, Pages 277-279

  Chen, Mi Na ^a   Mao, Qing ^a   Liu, Yan Hui ^a   Mao, Bo Yong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Meningioma; Methylation; Methylation specific polymerase chain reaction; Protein expression

Indexed keywords

PROTEIN P16;

ARTICLE; CANCER GRADING; CARCINOGENESIS; DNA METHYLATION; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MENINGIOMA; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; DNA METHYLATION; FEMALE; GENES, P16; GENES, RETINOBLASTOMA; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; PROTO-ONCOGENE PROTEINS;

EID: 2942754255     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Longstreth WT Jr, Dennis LK, McGuire VM, et al. Epidemiology of intracranial meningioma. Cancer, 1993, 72: 639-648.
2. Ueki K, Wen-Bin C, Narita Y, et al. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas. Cancer Res, 1999, 59: 5995-5998.
3. Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet, 2000, 16: 168-174.
4. Dong SM, Pang JC, Poon WS, et al. Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors. J Neuropathol Exp Neurol, 2001, 60: 808-816.
5. Esteller M, Corn PG, Baylin SB, et al. A gene hypermethylation profile of human cancer. Cancer Res, 2001, 61: 3225-3229.
6. Su CQ, Shan XN. Correlation of inactivation of CDKN2/p16 gene by methylation and lung cancer. Chin J Med Genet, 2000, 17: 36-38.
7. INK4a, pRb, and CDK4 in low- and high- grade meningiomas. Hum Pathol, 1998, 29: 1200-1207.
8. Bostrom J, Meyer-Puttlitz B, Wolter M, et al. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4h)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Am J Pathol, 2001, 159: 661-669.